Welcome back to Health Unlocked. In this episode, Jasen Petersen dives into the patient side of access to innovative wound care solutions like the Ion Gel, spotlighting how patients, providers, and small businesses can get involved in a rapidly evolving healthcare landscape. After exploring the infrastructural and supply-side mechanics in previous episodes, today’s conversation shifts to practical questions: How is this work being funded? Where can patients actually access these products? And what are the challenges for clinics and practitioners seeking to introduce new treatments? Jasen discusses regulatory pathways, real-world studies happening in Mexico, the importance of affordability, and creative ways ordinary businesses can support healthcare innovation like re-routing credit card processing fees to charitable foundations. Whether you’re a patient hoping for better outcomes, a clinician exploring new protocols, or simply someone curious about the future of patient-driven innovation, this episode is packed with insights you won’t want to miss.
Timestamps:
00:00 Discussing foundation's early funding
04:47 Discussing IP and community involvement
06:44 Availability of Ion Gel ZCM-25
12:38 Outsourcing for Safety and Efficiency
15:09 Insurance impact on wound care pricing
18:18 Conducting effective placebo-controlled trials
22:19 Efficacy and cost of cosmetic products
26:03 Challenges in Tracking Treatment Success
26:51 IonGel effectiveness and wound healing
33:27 Challenges with cardiogenic drug training
34:53 How cell-based treatments work
38:51 Adjusting cell dosage and frequency
42:57 Future plans for product distribution
45:53 From anecdotal evidence to medical use
Insights from “Health Unlocked: The Power of Salutogenesis” – Patient Access, Wound Care Innovations, and Affordable Health Solutions
The latest episode of “Health Unlocked: The Power of Salutogenesis” dives deep into the patient side of wound care, shedding light on the accessibility, affordability, and scientific considerations behind introducing new health technologies. Hosted by Jasen, the conversation focuses on how patients and providers can engage with new therapies, particularly the ion gel for wound healing, and the unique paths being pursued to keep these treatments within reach for all.
Shifting Focus to Patient Access
In this episode, Jasen underscores a significant shift from supply discussions to patient demand, highlighting efforts to build bridges between innovation and access. A primary goal is ensuring that patients and small businesses can get involved, benefit, and contribute to the future of wound care technology. The discussion begins with an explanation of initial funding structures, where foundation seeds mostly came from board contributions and private donors. This transparent approach sets the stage for future patient-centric initiatives, such as the decentralized science (DeSci) platform, aimed at distributing governance and equity via token sales.
Realities of Access: Where to Get Wound Healing Products
Access to wound healing products, specifically the ion gel, is currently limited geographically. As Jasen explains, the ZCM-25 ion gel is presently approved only in Mexico and the UAE. Patients outside these regions are limited to using IBAL-based cosmetic products, which cannot make medical claims but may offer general tissue support. For those interested, Jasen recommends visiting Atheon (aetheon.com), the main manufacturer, and offers to help with discounts for those who reach out. This practical tip opens the door for global listeners to explore available options even before widespread regulatory approval is achieved.
Opportunities for Providers: How Clinicians Can Get Involved
Regarding healthcare providers, Jasen emphasizes the role of IRB (Institutional Review Board) studies in safely and legally trialing new treatments that are not yet fully approved in their countries. The process, he notes, is often simpler and faster than anticipated, thanks to the clean safety profile and established efficacy in approved regions. Clinicians interested in running such studies are encouraged to reach out directly, tapping into the growing body of data and supporting both science and patient care. This opens a pathway for proactive providers to become early adopters and contributors to evidence-based innovation.
Navigating the Changing Market: The Push for Affordability
A key theme throughout the episode is affordability in the face of shifting reimbursement policies. Jasen explains that insurance coverage for advanced wound care products has been significantly cut, demanding a new approach that delivers results at lower prices. The ion gel, according to clinic data, competes favorably with much more expensive products, fitting perfectly into a market eager for cost-effective solutions. This reflects a broader transition where terrain-based approaches and salutogenic principles are challenging conventional expensive standards with smarter, science-backed alternatives.
Ensuring Quality and Consistency at Scale
As innovative treatments scale, maintaining quality and consistency becomes vital. Training for providers is crucial, as Jasen details, because new salutogenic products differ fundamentally from traditional therapies. Instead of seeking the minimum effective dose, clinicians are encouraged to supply what cells need for optimal healing. This approach is supported by surveillance data and ongoing provider education, minimizing risks of misuse and maximizing patient outcomes.
Forward-Looking Collaboration: Opportunities for Businesses and Practitioners
For those looking to collaborate, whether as clinics, distributors, or practitioners, the episode offers practical steps. Today, professionals can use cosmetic products within legal guidelines or initiate IRB studies for clinical research. Looking forward, partnerships with distributors are encouraged so that when regulatory pathways clear, approved products can rapidly reach those in need. Businesses processing credit cards are also invited to participate in a redirected fee program supporting the foundation while saving on operational costs.
Conclusion: Joining the Movement for Better Health
This episode of “Health Unlocked: The Power of Salutogenesis” demonstrates how transparent communication, evidence-based science, and collaborative opportunities are paving the way for better, more affordable wound care. Patients and providers alike are invited to join the conversation, reach out for more information, and help shape a future where innovative therapies are accessible and effective for all.
For more details, discounts, and direct engagement, listeners are encouraged to check the show notes and connect via the podcast website.
“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
Show Website - https://powerofsalutogenesis.com/
Ionic Alliance Foundation Website - https://iaf.care/
Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/
TopHealth Media Website - https://tophealth.care/